HealthSouth Corp (HLS) Issues FY14 Earnings Guidance
HealthSouth Corp (NYSE:HLS) issued an update on its FY14 earnings guidance on Wednesday morning. The company provided EPS guidance of $2.25-2.31 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.10, AnalystRatingsNetwork.com reports.
HealthSouth Corp (NYSE:HLS) opened at 39.39 on Wednesday. HealthSouth Corp has a 52-week low of $29.82 and a 52-week high of $42.41. The stock’s 50-day moving average is $38.64 and its 200-day moving average is $35.61. The company has a market cap of $3.456 billion and a P/E ratio of 23.57.
HealthSouth Corp (NYSE:HLS) last issued its quarterly earnings data on Monday, July 28th. The company reported $0.54 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.47 by $0.07. The company had revenue of $604.40 million for the quarter, compared to the consensus estimate of $588.94 million. During the same quarter in the prior year, the company posted $0.51 earnings per share. The company’s quarterly revenue was up 7.1% on a year-over-year basis. On average, analysts predict that HealthSouth Corp will post $2.10 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on HLS shares. Analysts at Zacks upgraded shares of HealthSouth Corp from a neutral rating to an outperform rating in a research note on Friday, August 1st. They now have a $40.90 price target on the stock. On a related note, analysts at RBC Capital raised their price target on shares of HealthSouth Corp from $37.00 to $41.00 in a research note on Thursday, July 31st. They now have an outperform rating on the stock. Finally, analysts at Barclays reiterated an equal weight rating on shares of HealthSouth Corp in a research note on Wednesday, July 30th. They now have a $44.00 price target on the stock, up previously from $36.00. Three equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $40.86.
HealthSouth Corporation (NYSE:HLS), is an owner and operator of inpatient rehabilitation hospitals.
Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.